Trial Condition(s):
Sunscreening Agents
Evaluation of Sunscreen During Exercise Under Conditions of Profuse Sweating (821/2016)
Bayer Identifier:
18821
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Study Completed
Trial Purpose
To visually evaluate the retention of coverage of the Test Product(s) (TP) on the face after exercise compared to the full coverage observed prior to exercise
Inclusion Criteria
Subjects may be male or female, of an age of 18-55 years inclusive. Subjects must be capable of understanding and providing written informed consent. Subjects must sign a written confidentiality agreement including a photography release form. Subjects must be in good general health as judged by a specified licensed physician, who will indicate their suitability to participate in this study.
Exclusion Criteria
Subjects must not have received or used an Investigational New Drug within the last 30 days. Subjects must not have been active participants in another clinical or subjective TP performance study within the last 30 days unless authorized by this Sponsor. Subjects must not have a known physical or medical condition that would preclude vigorous exercise Subjects must not have a five-minute resting pulse rate greater than 80 bpm.
Trial Summary
Enrollment Goal
17
Trial Dates
Phase
N/A
Could I receive a placebo?
No
Products
BAY987517
Accepts Healthy Volunteers
Yes
Where to Participate
Loading...
Locations
| Locations | |
|---|---|
Locations Hill Top Research St. Petersburg, United States, 33714 | Contact Us: E-mail: [email protected] Phone: ++4930300139003 |
Trial Design
Evaluation of Sunscreen During Exercise Under Conditions of Profuse Sweating
Trial Type:
Interventional
Intervention Type:
Drug
Trial Purpose:
Other
Allocation:
N/A
Blinding:
Open Label
Assignment:
Single Group Assignment
Trial Arms:
1
Primary Outcome
- Change of face coverage post exercise compared to the full coverage observed prior to exercise (in percent)The expert grader will determine the percentage of coverage achieved by viewing the subject’s face through the Skin ScannerTimeframe: At baseline, and post exercise (30 minutes)
Secondary Outcome
- Report of eye stinging assessed by questionnaireSubjective assessment of eye stinging (where 0=none to 4=severe)Timeframe: Up to 30 minutes
Additional Information
Copyright © Bayer
Powered by
